Analyze the effectiveness of CA-125 to detect ovarian and non-ovarian cancer.
Principal Investigator
Name
Joel Sokol
Degrees
Ph.D.
Institution
Georgia Institute of Technology
Position Title
Director, Master of Science Analytics
Email
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
PLCO-1253
Initial CDAS Request Approval
Jun 13, 2023
Title
Analyze the effectiveness of CA-125 to detect ovarian and non-ovarian cancer.
Summary
CA-125 is a common test ob/gyn typically orders to test for ovarian cancer. This marker alone, while a standard, often yields false positives. Preliminary research have shown that reviewing this marker a number of features can help provide guidance to physicians to preventative care. Quite often when this marker is elevated, patient is referred to oncologist for next stage of care. We'd like to explore ways to develop a system to help physicians deliver this news and encourage patients for early detection.
Aims
- Research and identify other supplemental markers in addition to CA-125 for ovarian cancer detection
- Create a system for medical professionals to gain insights into the probability of false positives
- Develop a system that encourage early detection and leverage trends as a marker instead of a one-off readout
Collaborators
Currently no other collaborators.